1999

133.- A.Edo, E.Murio, JL.Lázro, R.Charco, I.Bilbao, L.Pou, C.Margarit. Oral administration of tacrolimus (FK 506) as primary immunosuppresion in liver transplantation: a comparative study with conventional cyclosporine. Transplantology 1999; 10: 11-17
134.- Margarit C, Lazaro JL, Charco R, Hidalgo E, Revhaug A, Murio E. Liver transplantation in patients with splenorenal shunts: intraoperative flow measurements to indicate shunt occlusion. Liver Transpl Surg. 1999 Jan;5(1):35-9
135.- Galve ML, Cuervas-Mons V, Figueras J, Herrero I, Mata M, Clemente G, Prieto M, Margarit C, Bernardos A, Casafont F. Incidence and outcome of de novo malignancies after liver transplantation. Transplant Proc. 1999 Feb-Mar;31(1-2):1275-7
136.- Clemente G, Duran F, Loinaz C, Casanovas T, Rimola A, Jara P, Cuervas Mons V, Pons JA, Margarit C, Prieto M, de la Mata M, Barcena R, Casafont F, Suarez F, Quiroga JA, Varo E, Gonzalez A, Maldonado J, Suarez MJ. Late orthotopic liver retransplant: indications and survival. Liver Transplant Spanish Group. Transplant Proc. 1999 Feb-Mar;31(1-2):511-4
137.- Margarit C, Lazaro JL, Charco R, Hidalgo E, Mora A, Bilbao I, Murio E. Diminished portal and total hepatic blood flows after liver graft revascularization predicts severity of ischemic lesion. Transplant Proc. 1999 Feb-Mar;31(1-2):444
138.- Parrilla P, Sanchez-Bueno F, Figueras J, Jaurrieta E, Mir J, Margarit C, Lazaro J, Herrera L, Gomez-Fleitas M, Varo E, Vicente E, Robles R, Ramirez P. Analysis of the complications of the piggy-back technique in 1,112 liver transplants. Transplantation. 1999 May 15;67(9):1214-7
139.- Charco R, Cantarell C, Vargas V, Capdevila L, Lazaro JL, Hidalgo E, Murio E, Margarit C. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy. Liver Transpl Surg. 1999 May;5(3):204-8
140.- Castells L, Vargas V, Rodriguez-Frias F, Allende H, Jardi R, Margarit C, Esteban R, Guardia J. Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Transplant Proc. 1999 Sep;31(6):2464-5
141.- Hidalgo E, Cantarell C, Charco R, Murio E, Lazaro JL, Bilbao I, Margarit C. Risk factors for late hepatic artery thrombosis in adult liver transplantation. Transplant Proc. 1999 Sep;31(6):2416-7
142.- Parrilla P, Sanchez-Bueno F, Figueras J, Jaurrieta E, Mir J, Margarit C, Lazaro J, Herrera L, Gomez-Fleitas M, Varo E, Vicente E, Robles R, Ramirez P. Analysis of the complications of the piggy-back technique in 1112 liver transplants. Transplant Proc. 1999 Sep;31(6):2388-9
143.- Cantarell MC, Charco R, Capdevila L, Vargas V, Lazaro JL, Murio E, Piera L, Margarit C. Outcome of hepatitis C virus-associated membranoproliferative glomerulonephritis after liver transplantation. Transplantation. 1999 Oct 27;68(8):1131-4
144.- Charco R, Caragol I, Urban S, Lazaro JL, Murio E, Davila R, Margarit C. CD28 regulation in liver transplant recipients treated with two different immunosuppressive regimens. Transplant Proc. 1999 Dec;31(8):3365-6

web realizada por MediTecnologia
última actualización: 11/02/2005